Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Willemijn J. Jansen(Maastricht University), Lars Frings(University of Geneva), Gaël Chételat(Inserm), Olin Janssen(Maastricht University), Mark A. van Buchem(Seoul National University), Juan Fortea(Hospital de Sant Pau), Simone Baiardi(Istituto delle Scienze Neurologiche di Bologna), Alexa Pichet Binette(Lund University), Michel Bottlaender(Centre National de la Recherche Scientifique), Marion Delarue(Inserm), Randall J. Bateman(Washington University in St. Louis), Rik Ossenkoppele(Malmö University), Ann D. Cohen(University of Pittsburgh), Kaj Blennow(Sahlgrenska University Hospital), Anne M. Fagan(Washington University in St. Louis), Pieter Jelle Visser(Karolinska Institutet), Betty M. Tijms(Amsterdam Neuroscience), Mira Didic(Inserm), Yong Fan(University of Pennsylvania), Wiesje M. van der Flier(Amsterdam Neuroscience), Henryk Barthel(Leipzig University), Stefan Förster(German Center for Neurodegenerative Diseases), Marie Eckerström(University of Turku), Kristian Steen Frederiksen(University of Copenhagen), Sebastiaan Engelborghs(Vrije Universiteit Brussel), Alisha Daniels(Inserm), David J. Brooks(Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Henning Boecker(Centre National de la Recherche Scientifique), Anouk den Braber(Max Planck Institute for Psycholinguistics), Merçé Boada(Instituto de Salud Carlos III), Dag Aarsland(King's College London), Elena Chipi(University of Pittsburgh), Adam Fleisher(Banner Alzheimer’s Institute), Tormod Fladby(University of Oslo), Daniele Altomare(University of Applied Sciences and Arts of Southern Switzerland), Stephanie J. B. Vos(Maastricht University), Laura L. Ekblad(Vrije Universiteit Brussel), Bart van Berckel(Douglas Mental Health University Institute), Alexander Drzezga(Forschungszentrum Jülich), Christine A. F. Von Arnim(German Centre for Cardiovascular Research), Vincent Camus(Université de Tours), Inês Baldeiras(University of Coimbra), Yvonne Freund‐Levi(Karolinska Institutet), Daniel Alcolea(Hospital de Sant Pau), Stéphane Epelbaum(Washington University in St. Louis), Kewei Chen(Good Samaritan Medical Center), Jose Manuel Carill(Universidad de Cantabria), Jiří Cerman(Alzheimer's Association), Bruno Dubois(Sorbonne Université)
Cited by 281
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k